Recruiting studies: Hemosiderosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary He
Phase 2 · 99 location(s) · CSL Behring · NCT07332091 A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis
Phase 1/Phase 2 · 1 location(s) · Bond Biosciences · NCT07371793 An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603 Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematop
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07028112 Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children
Phase 1/Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05937191 China Registry for Genetic / Metabolic Liver Diseases
Phase N/A · 12 location(s) · Beijing Friendship Hospital · NCT03131427

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.